News

How do price caps on generic drugs affect cost and supply?

Aslam H. Anis. PhD, FCAHS. Professor, School of Population and Public Health, University of British Columbia

The goal of this research is to assess whether current price-cap regulations including the Pan-Canadian Generic Pricing Framework are efficient.

Read More

Promising New Findings on Using Biologic Drugs Before and During Pregnancy

Promising New Findings on Using Biologic Drugs Before and During Pregnancy   To...
Read More

Biologic drugs for spondyloarthritis patients: do policies in different countries affect costs and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

Using information from DESIR, researchers looked at which patients satisfied the criteria to receive biologic drugs in different countries: France, Canada, Germany, the United Kingdom and Hong Kong.

Read More

Biologic drugs for SpA: does following recommendations affect patients’ cost and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

This study used information from DESIR to look at the effect of following doctors’ recommendations about who should use biologic drugs.

Read More

How can we tell if Ankylosing Spondylitis care is being given according to recommendations?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

The study discovered that specialist doctors have some differences of opinion about recommended AS care.

Read More

 

LATEST NEWS

 

FULL-TIME RESEARCH ASSISTANT

Arthritis Research Canada (ARC) is an independent, not for profit charitable organization that is home to Canada’s largest and most successful clinical research centre. Since its creation in 1999, the Centre has earned international attention and recognition. The...

read more

COPD and Arthritis

  Dr. Diane Lacaille, Senior Research Scientist at Arthritis Research Canada, and her research team have recently learned that individuals with rheumatoid arthritis (RA) in British Columbia are more likely than others to develop COPD, or chronic obstructive...

read more

Les vaccins : ce que vous devez savoir

  On parle beaucoup d’immunisation ces derniers temps, mais que doivent savoir les personnes atteintes d'arthrite ou celles dont le système immunitaire est affaibli?   Tout d'abord, si vous utilisez des produits biologiques (une vaste gamme de produits...

read more

Biosimilars

  Why does a name say so much? If we called them off-patent or lower-cost drugs would the discussion still be the same? What if we said the Health Care budget would decrease without harm to a patient, would that matter?   So what is a biosimilar, and why do...

read more

Vaccines

  Vaccinations: there is a lot of talk about them these days, but what do people dealing with arthritis and/or a compromised immune system need to know?   First of all, if you are using biologics (a wide range of products isolated from natural sources used...

read more